viks
rgen
lm
leivestad
skjaerven
r
iversen
bm
preeclampsia
risk
endstag
renal
diseas
n
engl
j
med
viks
rgen
lm
bostad
l
iversen
bm
advers
perinat
outcom
later
kidney
biopsi
mother
j
soc
nephrol
viks
h
allan
bostad
l
leivestad
iversen
bm
previou
preeclampsia
risk
progress
biopsyverifi
ed
kidney
diseas
endstag
renal
diseas
nephrol
dial
transplant
wang
ik
mu
ch
chang
yc
et
al
associ
hypertens
disord
pregnanc
endstag
renal
diseas
populationbas
studi
cmaj
mcdonald
sd
han
z
walsh
mw
gerstein
hc
devereaux
pj
kidney
diseas
preeclampsia
systemat
review
metaanalysi
j
kidney
di
bellami
l
casa
jp
hingorani
ad
william
dj
preeclampsia
risk
cardiovascular
diseas
cancer
later
life
systemat
review
metaanalysi
bmj
garov
vd
wagner
sj
turner
st
et
al
urinari
podocyt
excret
marker
preeclampsia
j
obstet
gynecol
fisher
ka
luger
spargo
bh
lindheim
md
hypertens
pregnanc
clinicalpatholog
correl
remot
prognosi
medicin
baltimor
skjaerven
r
vatten
lj
wilcox
aj
ron
irgen
lm
lie
rt
recurr
preeclampsia
across
gener
explor
fetal
matern
genet
compon
popul
base
cohort
bmj
rasmussen
irgen
lm
pregnancyinduc
hypertens
women
born
small
hypertens
nanjundan
p
bagga
r
kalra
jk
thakur
js
raveendran
risk
factor
earli
onset
sever
preeclampsia
eclampsia
among
north
indian
women
guidanc
releas
may
establish
estim
diseas
sever
key
risk
assess
novel
infl
uenza
virus
unfortun
epidemiolog
assess
sever
diffi
cult
context
emerg
diseas
estim
need
guid
pandem
respons
case
fatal
risk
estim
proport
patient
specifi
c
diseas
die
howev
numer
denomin
estim
elus
case
detect
typic
skew
toward
patient
sever
diseas
laboratorybas
case
ascertain
vari
geograph
tempor
delay
onset
death
report
ing
potenti
lead
overestim
estim
fatal
risk
much
work
done
refi
ne
estim
case
fatal
risk
wake
outbreak
sever
acut
respiratori
syndrom
infl
uenza
pandem
diff
erent
denomin
con
sider
includ
patient
admit
hospit
symptomat
case
individu
serolog
evid
infect
statist
point
view
surviv
analysi
provid
appropri
framework
quantifi
case
fatal
rightcensor
outcom
data
lancet
hongji
yu
colleagu
assess
clinic
sever
human
infect
avian
infl
uenza
viru
basi
data
patient
laboratoryconfi
rmed
infect
admit
hospit
march
may
mainland
china
estim
fatal
risk
age
ci
note
nearli
patient
admit
intens
care
unit
receiv
mechan
ventil
die
patient
age
least
year
fatal
risk
higher
individu
younger
patient
typic
infl
u
enza
infect
obtain
estim
symptomat
case
fatal
risk
yu
colleagu
extrapol
total
number
symptomat
individu
infect
avian
infl
uenza
viru
basi
number
mild
case
detect
routin
infl
uenzalik
ill
surveil
shanghai
nanjingth
aff
ect
citi
estim
symptomat
case
fatal
risk
could
ci
per
symptomat
case
estim
highli
sensit
assumpt
test
propens
surveil
lanc
coverag
healthcar
seek
behaviour
use
nearrealtim
estim
case
fatal
risk
guid
polici
typic
limit
broad
uncertainti
tabl
earli
assess
pandem
infl
uenza
diseas
sever
inform
fi
rst
laboratoryconfi
rmed
case
produc
sever
estim
even
higher
yu
colleagu
new
estim
howev
estim
soon
downgrad
two
order
magnitud
inform
accumul
summer
tabl
similarli
sever
estim
avian
infl
uenza
viru
refi
ned
fate
patient
admit
hospit
resolv
serolog
attack
rate
becom
avail
attack
rate
could
gener
crosssect
survey
background
popul
immun
low
reassur
headtohead
comparison
fatal
risk
admit
patient
infect
avian
infl
uenza
suggest
substanti
milder
diseas
cours
use
estim
case
fatal
risk
extrapol
potenti
sever
full
pandem
would
tempt
howev
whether
global
dissemin
zoonot
infl
uenza
virus
would
result
catastroph
pandem
like
wors
would
mirror
mild
pandem
tabl
imposs
predict
remain
question
relat
age
distribut
symptomat
infect
zoonot
infl
uenza
viru
acquir
persontoperson
transmiss
far
age
distribut
report
case
infect
avian
infl
uenza
viru
skew
toward
old
age
probabl
explain
behaviour
age
diff
erenc
exposur
anim
reservoir
age
distribut
case
would
probabl
shift
toward
younger
age
full
pandem
result
diff
erent
potenti
decreas
case
fatal
risk
anoth
issu
would
account
potenti
chang
diseas
sever
viru
rapidli
evolv
although
convent
wisdom
stipul
virul
attenu
pathogen
adapt
new
host
anim
experi
suggest
infl
uenza
virul
could
increas
simultan
genet
drift
furthermor
evid
pandem
suggest
situat
escal
case
fatal
risk
increas
six
time
summer
autumn
good
news
number
case
avian
infl
uenza
viru
infect
stall
probabl
respons
preemptiv
closur
live
bird
market
howev
threat
viru
persist
continu
monitor
infect
togeth
nearrealtim
estim
case
fatal
risk
serolog
survey
remain
crucial
invest
robust
hospit
surveil
respiratori
infect
global
sampl
site
combin
laboratori
test
would
help
produc
compar
sever
estim
novel
exist
viral
threat
yu
colleagu
provid
best
sever
estim
avian
infl
uenza
viru
view
avail
inform
point
time
howev
public
health
expert
make
polici
decis
basi
uncomfort
broad
confi
denc
limit
although
progress
made
reduc
global
matern
mortal
estim
women
still
die
matern
mortal
disproportion
aff
ect
famili
live
lowincom
middleincom
countri
death
prevent
eff
ectiv
cheap
intervent
exist
prevent
death
major
caus
includ
haemor
rhage
hypertens
diseas
sepsi
septic
abort
lack
evid
impl
mentat
view
local
context
resourc
constraint
cultur
norm
mani
year
champion
multidisciplinari
matern
mortal
audit
essenti
reduc
death
audit
achiev
chang
must
willing
identifi
problem
leadership
capabl
motiv
institut
chang
audit
involv
far
count
death
perhap
surprisingli
given
complex
multidisciplinari
audit
date
evid
randomis
trial
show
reduct
matern
death
poor
lancet
alexandr
dumont
colleagu
address
knowledg
gap
fi
nding
quarit
trial
clusterrandomis
trial
done
hospit
across
seneg
mali
author
assess
complex
intervent
matern
mortal
audit
leadership
develop
train
emerg
obstetr
care
outreach
health
practition
educ
data
women
collect
year
give
studi
power
detect
chang
mortal
intervent
base
societi
obstetrician
gynaecologist
canada
alarm
advanc
labour
risk
manag
intern
program
programm
use
adult
learn
techniqu
teach
essenti
evidencebas
obstetr
skill
hospit
alloc
control
group
partak
intervent
continu
usual
care
result
show
greater
reduct
matern
death
intervent
compar
control
hospit
year
odd
ratio
ci
reduct
less
